Status:

TERMINATED

Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions

Lead Sponsor:

University Hospitals Cleveland Medical Center

Collaborating Sponsors:

Hospira, now a wholly owned subsidiary of Pfizer

Conditions:

Stroke

Brain Ischemia

Eligibility:

All Genders

18-85 years

Phase:

PHASE2

Brief Summary

Dexmedetomidine is a unique sedative medication able to provide sedation without causing respiratory depression and maintaining neurological functions. Patients having an acute ischemic stroke and nee...

Detailed Description

Precedex is a unique FDA-approved intravenous medication for conscious sedation in that it allows for "arousable" sedation, which is particularly appealing for use in patients with compromised neurolo...

Eligibility Criteria

Inclusion

  • Patients with acute ischemic stroke who require endovascular intervention with whom mNIHSS score can be obtained
  • Patients with cerebral vasospasm suspiciousness with or without subarachnoid hemorrhage with whom mNIHSS score can be obtained.

Exclusion

  • History of severe hepatic disease or severe renal disease (GFR\<20).
  • Hemodynamic instability.
  • Pregnancy.
  • Known allergy to study drug.
  • Evidence or history of cardiac electrophysiology instability including uncontrolled hemodynamically unstable complex atrial/ventricular arrhythmia or conduction block at the time of evaluation with the exception of atrial fibrillation, and heart rate less than 60 or systolic blood pressure less than 90.
  • Respiratory compromise requiring intubation.
  • Any medical (including history of cardiac conduction block, major hepatic or renal disease) or laboratory abnormality that may increase the risk associated with the trial participation or drug administration or may interfere with interpretation of trial results.

Key Trial Info

Start Date :

April 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2021

Estimated Enrollment :

7 Patients enrolled

Trial Details

Trial ID

NCT01845441

Start Date

April 1 2012

End Date

December 1 2021

Last Update

December 28 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospitals of Cleveland

Cleveland, Ohio, United States, 44106